Caricamento...
Clinical Trials: past, current and future for atypical parkinsonian syndromes
There are currently no effective, Food and Drug Administration (FDA) approved treatments for atypical parkinsonian disorders such as progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), dementia with lewy bodies (DLB) or multiple system atrophy (MSA). Previous treatment trials for...
Salvato in:
| Pubblicato in: | Semin Neurol |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4920046/ https://ncbi.nlm.nih.gov/pubmed/24963682 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0034-1381739 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|